SPOTLIGHT: Colorado passes $26.5M biotech incentive bill
Like so many other regions, Colorado is hoping to get its own slice of the biotech industry pie with the passage of a $26.5 million incentive bill. The bill "provides grants for five years to Colorado startup companies and research institutions seeking to commercialize new biotech drugs, biofuels, medical devices and nanotechnology," reports the Colorado Business Journal. Thirty percent of the funds will go to university and research institution technology transfer offices, thirty percent will go to start-up bioscience companies, and forty percent will be used to support the development of public-private infrastructure that will help commercialize Colorado's bioscience research. Release | Report
Be the first to comment Rate it:
Comments
Post new comment
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends

